Aeglea BioTherapeutics

Biotechnology Research • Austin, Texas, United States • 11-20 Employees

Company overview

Headquarters	805 Las Cimas Pkwy, Suite 100, Austin, Texas 78746, US
Phone number	+16176515940
Website	aeglea.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Biotech, Rare Disease, Human Enzymes, Engineering Enzymes
Founded	2013
Employees	11-20
Socials

Key Contacts at Aeglea BioTherapeutics

Michelle Burgess

Director Quality Operations

Gillian Bubb

Senior Director Clinical Science, Clinical Development. Rare Genetic Disease

Scott Horton

Director, Statistical Programming

Mathoor Sivaram

Assoicate Director

Aeglea BioTherapeutics Email Formats

Aeglea BioTherapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@aeglea.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@aeglea.com	100%

About Aeglea BioTherapeutics

With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD. For more information, please visit http://aeglea.com.

Aeglea BioTherapeutics revenue & valuation

Annual revenue	$886,000
Revenue per employee	$74,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,900,000
Total funding	$210,000,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Entry

Manager

Employees by Department

Aeglea BioTherapeutics has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Aeglea BioTherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-22	14	$210,000,000

Funding Insights

$210,000,000

Total funding amount

$210,000,000

Most recent funding amount

Number of funding rounds

Aeglea BioTherapeutics Tech Stack

Discover the technologies and tools that power Aeglea BioTherapeutics's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Google Tag Manager

Tag managers

HSTS

Security

React

JavaScript frameworks

Sanity

CMS

PWA

Miscellaneous

Netlify

CDN

Gatsby

JavaScript frameworks

Webpack

Miscellaneous

Frequently asked questions

Aeglea BioTherapeutics is located in Austin, Texas, US.

You can reach Aeglea BioTherapeutics at +16176515940.

Aeglea BioTherapeutics was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Aeglea BioTherapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Aeglea BioTherapeutics has raised a total of $210,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.